目次

Table of Contents

1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions

2 Group of Eight (G8) Generics
2.1. Industry Outlook

3 Generics in Canada
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis

4 Macroeconomic Indicators
4.1. Country data

5 Generics in France
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis

6 Macroeconomic Indicators
6.1. Country data

7 Generics in Germany
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis

8 Macroeconomic Indicators
8.1. Country data

9 Generics in Italy
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis

10 Macroeconomic Indicators
10.1. Country data

11 Generics in Japan
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis

12 Macroeconomic Indicators
12.1. Country data

13 Generics in Russia
13.1. Market Overview
13.2. Market Data
13.3. Market Segmentation
13.4. Market outlook
13.5. Five forces analysis

14 Macroeconomic Indicators
14.1. Country data

15 Generics in The United Kingdom
15.1. Market Overview
15.2. Market Data
15.3. Market Segmentation
15.4. Market outlook
15.5. Five forces analysis

16 Macroeconomic Indicators
16.1. Country data

17 Generics in The United States
17.1. Market Overview
17.2. Market Data
17.3. Market Segmentation
17.4. Market outlook
17.5. Five forces analysis

18 Macroeconomic Indicators
18.1. Country data

19 Company Profiles
19.1. Teva Pharmaceutical Industries Ltd
19.2. Viatris Inc
19.3. Sun Pharmaceutical Industries Ltd
19.4. Novartis AG
19.5. Sandoz Group AG
19.6. Hikma Pharmaceuticals Plc
19.7. Sanofi
19.8. Les Laboratoires Servier SAS
19.9. Stada Arzneimittel AG
19.10. Bayer AG
19.11. Lupin Ltd
19.12. Aspen Pharmacare Holdings Ltd
19.13. EMS SA
19.14. Eurofarma Laboratorios SA
19.15. Ache Laboratorios Farmaceuticos SA
19.16. Apotex Inc
19.17. Teva Canada Ltd
19.18. Sandoz Canada Inc
19.19. CSPC Pharmaceutical Group Ltd
19.20. Sino Biopharmaceutical Ltd
19.21. Hansoh Pharmaceutical Group Co Ltd
19.22. Dr. Reddy's Laboratories Ltd
19.23. Cipla Ltd
19.24. Aurobindo Pharma Ltd
19.25. PT Kalbe Farma Tbk
19.26. PT Indofarma Tbk
19.27. PT Sanbe Farma
19.28. PT Soho Global Health Tbk
19.29. Friulchem SpA
19.30. DOC Generici SRL
19.31. Recordati SpA
19.32. Daiichi Sankyo Co Ltd
19.33. Towa Pharmaceutical Co Ltd
19.34. Sawai Group Holdings Co Ltd
19.35. Toho Holdings Co Ltd
19.36. Laboratorios Silanes SA de CV
19.37. Pfizer Inc
19.38. Biocad
19.39. R-Pharm
19.40. Pharmstandard
19.41. AstraZeneca Plc
19.42. Bluefish Pharmaceuticals AB
19.43. Navamedic ASA
19.44. Novartis International AG
19.45. Beacons Pharmaceuticals Pte Ltd
19.46. Abbott Laboratories SA
19.47. Adcock Ingram Holdings Ltd
19.48. Dongkook Pharmaceutical Co Ltd
19.49. JW Holdings Corp
19.50. Hanmi Pharmaceuticals Co Ltd
19.51. Dong Wha Pharma Co Ltd
19.52. Esteve Pharmaceuticals SA
19.53. Abdi Ibrahim Ilac Sanayi ve Ticaret AS
19.54. Deva Holding AS
19.55. Sandoz Inc

20 Appendix
20.1. Methodology
20.2. About MarketLine

List of Tables
Table 1: G8 generics industry, revenue($m), 2019-28
Table 2: G8 generics industry, revenue by country ($m), 2019-23
Table 3: G8 generics industry forecast, revenue by country ($m), 2023-28
Table 4: Canada generics market value: $ million, 2018-23
Table 5: Canada generics market volume: % of total pharma volume, 2018-23
Table 6: Canada generics market geography segmentation: $ million, 2023
Table 7: Canada generics market value forecast: $ million, 2023-28
Table 8: Canada generics market volume forecast: % of total pharma volume, 2023-28
Table 9: Canada Size of Population (million), 2019-23
Table 10: Canada real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 11: Canada GDP (Current Prices, $ Billion), 2019-23
Table 12: Canada Inflation, 2019-23
Table 13: Canada Consumer Price Index (Absolute), 2019-23
Table 14: Canada exchange rate, 2018-23
Table 15: France generics market value: $ million, 2018-23
Table 16: France generics market volume: % of total pharma volume, 2018-23
Table 17: France generics market geography segmentation: $ million, 2023
Table 18: France generics market value forecast: $ million, 2023-28
Table 19: France generics market volume forecast: % of total pharma volume, 2023-28
Table 20: France Size of Population (million), 2019-23
Table 21: France real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 22: France GDP (Current Prices, $ Billion), 2019-23
Table 23: France Inflation, 2019-23
Table 24: France Consumer Price Index (Absolute), 2019-23
Table 25: France exchange rate, 2018-23
Table 26: Germany generics market value: $ million, 2018-23
Table 27: Germany generics market volume: % of total pharma volume, 2018-23
Table 28: Germany generics market geography segmentation: $ million, 2023
Table 29: Germany generics market value forecast: $ million, 2023-28
Table 30: Germany generics market volume forecast: % of total pharma volume, 2023-28
Table 31: Germany Size of Population (million), 2019-23
Table 32: Germany real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 33: Germany GDP (Current Prices, $ Billion), 2019-23
Table 34: Germany Inflation, 2019-23
Table 35: Germany Consumer Price Index (Absolute), 2019-23
Table 36: Germany exchange rate, 2018-23
Table 37: Italy generics market value: $ million, 2018-23
Table 38: Italy generics market volume: % of total pharma volume, 2018-23
Table 39: Italy generics market geography segmentation: $ million, 2023
Table 40: Italy generics market value forecast: $ million, 2023-28
Table 41: Italy generics market volume forecast: % of total pharma volume, 2023-28
Table 42: Italy Size of Population (million), 2019-23
Table 43: Italy real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 44: Italy GDP (Current Prices, $ Billion), 2019-23
Table 45: Italy Inflation, 2019-23
Table 46: Italy Consumer Price Index (Absolute), 2019-23
Table 47: Italy exchange rate, 2018-23
Table 48: Japan generics market value: $ million, 2018-23
Table 49: Japan generics market volume: % of total pharma volume, 2018-23
Table 50: Japan generics market geography segmentation: $ million, 2023
Table 51: Japan generics market value forecast: $ million, 2023-28
Table 52: Japan generics market volume forecast: % of total pharma volume, 2023-28
Table 53: Japan Size of Population (million), 2019-23
Table 54: Japan real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 55: Japan GDP (Current Prices, $ Billion), 2019-23
Table 56: Japan Inflation, 2019-23
Table 57: Japan Consumer Price Index (Absolute), 2019-23
Table 58: Japan exchange rate, 2018-23
Table 59: Russia generics market value: $ million, 2018-23
Table 60: Russia generics market volume: % of total pharma volume, 2018-23
Table 61: Russia generics market geography segmentation: $ million, 2023
Table 62: Russia generics market value forecast: $ million, 2023-28
Table 63: Russia generics market volume forecast: % of total pharma volume, 2023-28
Table 64: Russia Size of Population (million), 2019-23
Table 65: Russia real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 66: Russia GDP (Current Prices, $ Billion), 2019-23
Table 67: Russia Inflation, 2019-23
Table 68: Russia Consumer Price Index (Absolute), 2019-23
Table 69: Russia exchange rate, 2018-23
Table 70: United Kingdom generics market value: $ million, 2018-23
Table 71: United Kingdom generics market volume: % of total pharma volume, 2018-23
Table 72: United Kingdom generics market geography segmentation: $ million, 2023
Table 73: United Kingdom generics market value forecast: $ million, 2023-28
Table 74: United Kingdom generics market volume forecast: % of total pharma volume, 2023-28
Table 75: United Kingdom Size of Population (million), 2019-23
Table 76: United Kingdom real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 77: United Kingdom GDP (Current Prices, $ Billion), 2019-23
Table 78: United Kingdom Inflation, 2019-23
Table 79: United Kingdom Consumer Price Index (Absolute), 2019-23
Table 80: United Kingdom exchange rate, 2018-23
Table 81: United States generics market value: $ million, 2018-23
Table 82: United States generics market volume: % of total pharma volume, 2018-23
Table 83: United States generics market geography segmentation: $ million, 2023
Table 84: United States generics market value forecast: $ million, 2023-28
Table 85: United States generics market volume forecast: % of total pharma volume, 2023-28
Table 86: United States Size of Population (million), 2019-23
Table 87: United States real GDP (Constant 2010 Prices, $ billion), 2019-23
Table 88: United States GDP (Current Prices, $ Billion), 2019-23
Table 89: United States Inflation, 2019-23
Table 90: United States Consumer Price Index (Absolute), 2019-23
Table 91: United States exchange rate, 2018-23
Table 92: Teva Pharmaceutical Industries Ltd: key facts
Table 93: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 94: Teva Pharmaceutical Industries Ltd: Key Employees
Table 95: Viatris Inc: key facts
Table 96: Viatris Inc: Annual Financial Ratios
Table 97: Viatris Inc: Key Employees
Table 98: Sun Pharmaceutical Industries Ltd: key facts
Table 99: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 100: Sun Pharmaceutical Industries Ltd: Key Employees

List of Figures
Figure 1: G8 generics industry, revenue($m), 2019-28
Figure 2: G8 Generics industry, revenue by country (%), 2023
Figure 3: G8 generics industry, revenue by country ($m), 2019-23
Figure 4: G8 generics industry forecast, revenue by country ($m), 2023-28
Figure 5: Canada generics market value: $ million, 2018-23
Figure 6: Canada generics market volume: % of total pharma volume, 2018-23
Figure 7: Canada generics market geography segmentation: % share, by value, 2023
Figure 8: Canada generics market value forecast: $ million, 2023-28
Figure 9: Canada generics market volume forecast: % of total pharma volume, 2023-28
Figure 10: Forces driving competition in the generics market in Canada, 2023
Figure 11: Drivers of buyer power in the generics market in Canada, 2023
Figure 12: Drivers of supplier power in the generics market in Canada, 2023
Figure 13: Factors influencing the likelihood of new entrants in the generics market in Canada, 2023
Figure 14: Factors influencing the threat of substitutes in the generics market in Canada, 2023
Figure 15: Drivers of degree of rivalry in the generics market in Canada, 2023
Figure 16: France generics market value: $ million, 2018-23
Figure 17: France generics market volume: % of total pharma volume, 2018-23
Figure 18: France generics market geography segmentation: % share, by value, 2023
Figure 19: France generics market value forecast: $ million, 2023-28
Figure 20: France generics market volume forecast: % of total pharma volume, 2023-28
Figure 21: Forces driving competition in the generics market in France, 2023
Figure 22: Drivers of buyer power in the generics market in France, 2023
Figure 23: Drivers of supplier power in the generics market in France, 2023
Figure 24: Factors influencing the likelihood of new entrants in the generics market in France, 2023
Figure 25: Factors influencing the threat of substitutes in the generics market in France, 2023
Figure 26: Drivers of degree of rivalry in the generics market in France, 2023
Figure 27: Germany generics market value: $ million, 2018-23
Figure 28: Germany generics market volume: % of total pharma volume, 2018-23
Figure 29: Germany generics market geography segmentation: % share, by value, 2023
Figure 30: Germany generics market value forecast: $ million, 2023-28
Figure 31: Germany generics market volume forecast: % of total pharma volume, 2023-28
Figure 32: Forces driving competition in the generics market in Germany, 2023
Figure 33: Drivers of buyer power in the generics market in Germany, 2023
Figure 34: Drivers of supplier power in the generics market in Germany, 2023
Figure 35: Factors influencing the likelihood of new entrants in the generics market in Germany, 2023
Figure 36: Factors influencing the threat of substitutes in the generics market in Germany, 2023
Figure 37: Drivers of degree of rivalry in the generics market in Germany, 2023
Figure 38: Italy generics market value: $ million, 2018-23
Figure 39: Italy generics market volume: % of total pharma volume, 2018-23
Figure 40: Italy generics market geography segmentation: % share, by value, 2023
Figure 41: Italy generics market value forecast: $ million, 2023-28
Figure 42: Italy generics market volume forecast: % of total pharma volume, 2023-28
Figure 43: Forces driving competition in the generics market in Italy, 2023
Figure 44: Drivers of buyer power in the generics market in Italy, 2023
Figure 45: Drivers of supplier power in the generics market in Italy, 2023
Figure 46: Factors influencing the likelihood of new entrants in the generics market in Italy, 2023
Figure 47: Factors influencing the threat of substitutes in the generics market in Italy, 2023
Figure 48: Drivers of degree of rivalry in the generics market in Italy, 2023
Figure 49: Japan generics market value: $ million, 2018-23
Figure 50: Japan generics market volume: % of total pharma volume, 2018-23
Figure 51: Japan generics market geography segmentation: % share, by value, 2023
Figure 52: Japan generics market value forecast: $ million, 2023-28
Figure 53: Japan generics market volume forecast: % of total pharma volume, 2023-28
Figure 54: Forces driving competition in the generics market in Japan, 2023
Figure 55: Drivers of buyer power in the generics market in Japan, 2023
Figure 56: Drivers of supplier power in the generics market in Japan, 2023
Figure 57: Factors influencing the likelihood of new entrants in the generics market in Japan, 2023
Figure 58: Factors influencing the threat of substitutes in the generics market in Japan, 2023
Figure 59: Drivers of degree of rivalry in the generics market in Japan, 2023
Figure 60: Russia generics market value: $ million, 2018-23
Figure 61: Russia generics market volume: % of total pharma volume, 2018-23
Figure 62: Russia generics market geography segmentation: % share, by value, 2023
Figure 63: Russia generics market value forecast: $ million, 2023-28
Figure 64: Russia generics market volume forecast: % of total pharma volume, 2023-28
Figure 65: Forces driving competition in the generics market in Russia, 2023
Figure 66: Drivers of buyer power in the generics market in Russia, 2023
Figure 67: Drivers of supplier power in the generics market in Russia, 2023
Figure 68: Factors influencing the likelihood of new entrants in the generics market in Russia, 2023
Figure 69: Factors influencing the threat of substitutes in the generics market in Russia, 2023
Figure 70: Drivers of degree of rivalry in the generics market in Russia, 2023
Figure 71: United Kingdom generics market value: $ million, 2018-23
Figure 72: United Kingdom generics market volume: % of total pharma volume, 2018-23
Figure 73: United Kingdom generics market geography segmentation: % share, by value, 2023
Figure 74: United Kingdom generics market value forecast: $ million, 2023-28
Figure 75: United Kingdom generics market volume forecast: % of total pharma volume, 2023-28
Figure 76: Forces driving competition in the generics market in the United Kingdom, 2023
Figure 77: Drivers of buyer power in the generics market in the United Kingdom, 2023
Figure 78: Drivers of supplier power in the generics market in the United Kingdom, 2023
Figure 79: Factors influencing the likelihood of new entrants in the generics market in the United Kingdom, 2023
Figure 80: Factors influencing the threat of substitutes in the generics market in the United Kingdom, 2023
Figure 81: Drivers of degree of rivalry in the generics market in the United Kingdom, 2023
Figure 82: United States generics market value: $ million, 2018-23
Figure 83: United States generics market volume: % of total pharma volume, 2018-23
Figure 84: United States generics market geography segmentation: % share, by value, 2023
Figure 85: United States generics market value forecast: $ million, 2023-28
Figure 86: United States generics market volume forecast: % of total pharma volume, 2023-28
Figure 87: Forces driving competition in the generics market in the United States, 2023
Figure 88: Drivers of buyer power in the generics market in the United States, 2023
Figure 89: Drivers of supplier power in the generics market in the United States, 2023
Figure 90: Factors influencing the likelihood of new entrants in the generics market in the United States, 2023
Figure 91: Factors influencing the threat of substitutes in the generics market in the United States, 2023
Figure 92: Drivers of degree of rivalry in the generics market in the United States, 2023